246 Hits
Mani
Jun 22, 2022, 4:18 PM
The analysis examined digital health companies using the Rock Health Digital Health Venture Funding Database, FDA data on 510(k), De Novo and premarket approval filings, and the number and type of clinical trials listed on ClinicalTrials.gov. Researchers then assigned a "clinical robustness" score for each company, the sum of the number of regulatory filings and clinical trials weighted equally.
Read More
